Compare STEM & XGN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | STEM | XGN |
|---|---|---|
| Founded | 2009 | 2002 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Computer Software: Prepackaged Software | Medical Specialities |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 75.3M | 65.9M |
| IPO Year | 2020 | 2014 |
| Metric | STEM | XGN |
|---|---|---|
| Price | $10.82 | $3.04 |
| Analyst Decision | Hold | Strong Buy |
| Analyst Count | 3 | 7 |
| Target Price | ★ $13.33 | $8.86 |
| AVG Volume (30 Days) | 90.9K | ★ 182.9K |
| Earning Date | 05-06-2026 | 05-11-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $156,266,000.00 | N/A |
| Revenue This Year | $2.77 | $8.12 |
| Revenue Next Year | $14.65 | $13.00 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | ★ 8.08 | N/A |
| 52 Week Low | $0.35 | $2.59 |
| 52 Week High | $32.23 | $12.23 |
| Indicator | STEM | XGN |
|---|---|---|
| Relative Strength Index (RSI) | 52.28 | 54.71 |
| Support Level | $9.72 | $2.61 |
| Resistance Level | $10.99 | $3.29 |
| Average True Range (ATR) | 0.83 | 0.18 |
| MACD | 0.04 | 0.02 |
| Stochastic Oscillator | 37.00 | 70.16 |
Stem Inc is a provider of energy storage systems. The company bundles third-party hardware with its proprietary Athena software to provide customers a turnkey solution. Stem sells its solutions to commercial and industrial customers as well as independent power producers and renewable developers. Its solutions help customers maximize renewable energy generation and help build a cleaner and more resilient grid. The Company operates as one operating segment that is focused exclusively on technology services that transform the way energy is distributed and consumed.
Exagen Inc is a medical technology company focused on the design, development and commercialization of diagnostic testing products under its AVISE brand. These products are used for the differential diagnosis, prognosis, and monitoring of rheumatic, autoimmune, and related diseases, including systemic lupus erythematosus (SLE) and rheumatoid arthritis (RA). The company operates in one operating segment. The majority of the company's revenue is derived from sales of its testing products.